Antioxidant supplementation lowers circulating IGF-1 but not F 2-isoprostanes immediately following anterior cruciate ligament surgery

Redox Report

Volumn 14, Issue 5, 2009, Pages 221-226

  Barker, Tyler ^a,b,c   Leonard, Scott W ^c   Trawick, Roy H ^a,d   Walker, James A ^a   Traber, Maret G ^b,c  

^a Orthopedic Specialty Hospital   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d The Orthopedic Specialty Clinic   (United States)

Author keywords

Anterior cruciate ligament; Cytokines; Insulin like growth factor1; Oxidative stress; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; INTERLEUKIN 10; ISOPROSTANE DERIVATIVE; SOMATOMEDIN C;

ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTERIOR CRUCIATE LIGAMENT; ANTIOXIDANTS; ASCORBIC ACID; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; F2-ISOPROSTANES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; VITAMIN E;

EID: 73649104061     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/135100009X12525712409535     Document Type: Article

References (33)

1. Dominguez-Rodriguez A, Abreu-Gonzalez P, De La Rosa A, Vargas M, Ferrer J, Garcia M. Role of endogenous interleukin-10 production and lipid peroxidation in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty, interleukin-10 and primary angioplasty. Int J Cardiol 2005; 99: 77-81.
2. Deblier I, Sadowska AM, Janssens A, Rodrigus I, DeBacker WA. Markers of inflammation and oxidative stress in patients undergoing CABG with CPB with and without ventilation of the lungs: a pilot study. Interact Cardiovasc Thorac Surg 2006; 5: 387-391.
3. Barker T, Leonard SW, Trawick RH, et al. Modulation of inflammation by vitamin E and C supplementation prior to anterior cruciate ligament surgery. Free Radic Biol Med 2009; 46: 599-606.
4. Daftarian PM, Kumar A, Kryworuchko M, Diaz-Mitoma F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. J Immunol 1996; 157: 12-20.
5. Wanidworanun C, Strober W. Predominant role of tumor necrosis factoralpha in human monocyte IL-10 synthesis. J Immunol 1993; 151: 6853-6861.
6. Tilg H, Atkins MB, Dinarello CA, Mier JW. Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy. Cytokine 1995; 7: 734-739.
7. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822.
8. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigenpresenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-3451.
9. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992; 267: 23301-23308.
10. Le Moine O, Stordeur P, Schandene L, et al. Adenosine enhances IL-10 secretion by humanmonocytes. J Immunol 1996; 156: 4408-4414.
11. Haddad JJ, Fahlman CS. Redox-and oxidant-mediated regulation of interleukin-10: an anti inflammatory, antioxidant cytokine? Biochem Biophys Res Commun 2002; 297: 163-176.
12. Warzecha Z, Dembinski A, Ceranowicz P, et al. IGF-1 stimulates production of interleukin-10 and inhibits development of caeruleininduced pancreatitis. J Physiol Pharmacol 2003; 54: 575-590.
13. Kooijman R, Coppens A. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leukoc Biol 2004; 76: 862-867.
14. Jeschke MG, Barrow RE, Suzuki F, Rai J, Benjamin D, Herndon DN. IGF-I/IGFBP-3 equilibrates ratios of proto anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol Med 2002; 8: 238-246.
15. Suzuki N, Motohashi N, Uezumi A, et al. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 2007; 117: 2468-2476.
16. Levine S, Nguyen T, Taylor N, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 2008; 358: 1327-1335.
17. Muller FL, Song W, Jang YC, et al. Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production. Am J Physiol 2007; 293: R1159-R1168.
18. Servais S, Letexier D, Favier R, Duchamp C, Desplanches D. Prevention of unloading-induced atrophy by vitamin E supplementation: links between oxidative stress and soleus muscle proteolysis? Free Radic Biol Med 2007; 42: 627-635.
19. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005; 37: 1974-1984.
20. Coleman ME, DeMayo F, Yin KC, et al. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 1995; 270: 12109-12116.
21. Musaro A, McCullagh K, Paul A, et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001; 27: 195-200.
22. Rommel C, Bodine SC, Clarke BA, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001; 3: 1009-1013.
23. 2-isoprostanes. Anal Biochem 2006; 350: 41-45.
24. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991; 28: 504-508.
25. Hong YL, Yeh SL, Chang CY, Hu ML. Total plasma malondialdehyde levels in 16 Taiwanese college students determined by various thiobarbituric acid tests and an improved high performance liquid chromatography-based method. Clin Biochem 2000; 33: 619-625.
26. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383-9387.
27. McAdam BF, Mardini IA, Habib A, et al. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest 2000; 105: 1473-1482.
28. Wu D, Mura C, Beharka AA, et al. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Physiol 1998; 275: C661-C668.
29. Granado M, Martin AI, Villanua MA, Lopez-Calderon A. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation. Am J Physiol 2007; 292: E1656-E1665.
30. Niebauer J, Pflaum CD, Clark AL, et al. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 1998; 32: 393-397.
31. Dehoux M, Van Beneden R, Pasko N, et al. Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes. Endocrinology 2004; 145: 4806-4812.
32. Broussard SR, McCusker RH, Novakofski JE, et al. IL-1beta impairs insulin-like growth factor I-induced differentiation and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. J Immunol 2004; 172: 7713-7720.
33. Broussard SR, McCusker RH, Novakofski JE, et al. Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Endocrinology 2003; 144: 2988-2996.